Patten Group, Inc. Novartis Ag Transaction History

Patten Group, Inc.

$460 Million
Q2 2025

A detailed history of Patten Group, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Patten Group, Inc. holds 16,853 shares of NVS stock, worth $2.2 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares

16,853

Previous 16,970 0.69%

Holding current value

$2.2 Million

Previous $1.89 Million 7.83%

% of portfolio

0.44%

Previous 0.44%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 30, 2025	SELL	$101.96 - $121.01 $11,929 - $14,158	-117 Reduced 0.69%	16,853 $2.04 Million
Q1 2025 May 14, 2025	BUY	$97.14 - $115.57 $61,101 - $72,693	629 Added 3.85%	16,970 $1.89 Million
Q4 2024 Feb 06, 2025	SELL	$96.78 - $117.18 $4,451 - $5,390	-46 Reduced 0.28%	16,341 $1.59 Million
Q3 2024 Oct 08, 2024	SELL	$106.13 - $120.89 $13,372 - $15,232	-126 Reduced 0.76%	16,387 $1.88 Million
Q2 2024 Jul 25, 2024	BUY	$92.57 - $107.37 $37,305 - $43,270	403 Added 2.5%	16,513 $1.76 Million
Q4 2023 Jan 10, 2024	BUY	$92.27 - $101.54 $27,588 - $30,360	299 Added 1.89%	16,110 $1.63 Million
Q3 2023 Oct 12, 2023	BUY	$94.73 - $105.13 $1,799 - $1,997	19 Added 0.12%	15,811 $1.61 Million
Q1 2023 Apr 06, 2023	BUY	$80.03 - $92.81 $9,443 - $10,951	118 Added 0.75%	15,792 $1.45 Million
Q4 2022 Feb 10, 2023	BUY	$75.55 - $92.52 $35,130 - $43,021	465 Added 3.06%	15,674 $1.42 Million
Q2 2022 Jul 18, 2022	BUY	$80.52 - $93.75 $724 - $843	9 Added 0.06%	15,209 $1.28 Million
Q1 2022 Apr 28, 2022	BUY	$80.11 - $90.62 $63,367 - $71,680	791 Added 5.49%	15,200 $1.33 Million
Q4 2021 Jan 20, 2022	BUY	$79.7 - $88.13 $3,825 - $4,230	48 Added 0.33%	14,409 $1.26 Million
Q3 2021 Nov 15, 2021	SELL	$81.78 - $95.14 $4,906 - $5,708	-60 Reduced 0.42%	14,361 $1.17 Million
Q2 2021 Aug 03, 2021	SELL	$85.24 - $94.15 $100,242 - $110,720	-1,176 Reduced 7.54%	14,421 $1.32 Million
Q1 2021 Apr 23, 2021	BUY	$83.5 - $98.47 $2,254 - $2,658	27 Added 0.17%	15,597 $1.33 Million
Q4 2020 Feb 02, 2021	SELL	$78.07 - $94.43 $17,956 - $21,718	-230 Reduced 1.46%	15,570 $1.47 Million
Q3 2020 Oct 19, 2020	BUY	$82.14 - $91.0 $4,517 - $5,005	55 Added 0.35%	15,800 $1.37 Million
Q2 2020 Jul 20, 2020	SELL	$80.93 - $91.1 $38,279 - $43,090	-473 Reduced 2.92%	15,745 $1.38 Million
Q1 2020 Apr 16, 2020	SELL	$70.67 - $99.01 $79,857 - $111,881	-1,130 Reduced 6.51%	16,218 $1.34 Million
Q4 2019 Jan 14, 2020	SELL	$84.35 - $95.37 $9,025 - $10,204	-107 Reduced 0.61%	17,348 $1.64 Million
Q3 2019 Oct 22, 2019	SELL	$85.54 - $94.26 $7,270 - $8,012	-85 Reduced 0.48%	17,455 $1.52 Million
Q2 2019 Jul 11, 2019	BUY	$75.4 - $92.8 $16,663 - $20,508	221 Added 1.28%	17,540 $1.6 Million
Q1 2019 May 14, 2019	BUY	$75.32 - $86.15 $16,796 - $19,211	223 Added 1.3%	17,319 $1.67 Million
Q4 2018 Feb 12, 2019	SELL	$73.66 - $82.02 $58,486 - $65,123	-794 Reduced 4.44%	17,096 $1.47 Million
Q3 2018 Nov 14, 2018	SELL	$66.94 - $77.43 $44,180 - $51,103	-660 Reduced 3.56%	17,890 $1.54 Million
Q2 2018 Aug 14, 2018	SELL	$64.91 - $73.36 $55,238 - $62,429	-851 Reduced 4.39%	18,550 $1.4 Million
Q1 2018 May 11, 2018	SELL	$70.39 - $84.15 $6,757 - $8,078	-96 Reduced 0.49%	19,401 $1.57 Million
Q4 2017 Feb 02, 2018	SELL	$72.33 - $77.64 $39,130 - $42,003	-541 Reduced 2.7%	19,497 $1.64 Million
Q3 2017 Dec 13, 2017	SELL	$74.14 - $77.27 $2.95 Million - $3.08 Million	-39,844 Reduced 66.54%	20,038 $1.72 Million
Q3 2017 Nov 14, 2017	BUY	$74.14 - $77.27 $2.95 Million - $3.08 Million	39,844 Added 198.84%	59,882 $1.72 Million
Q2 2017 Aug 14, 2017	BUY	N/A	20,038	20,038 $1.7 Million

Others Institutions Holding NVS

# of Institutions

1,561

Shares Held

136M

Call Options Held

1.72M

Put Options Held

1.7M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $281B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Patten Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Patten Group, Inc. with notifications on news.

Account